Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg
Ahmedabad, India | July 15, 2025 Zydus Lifesciences Limited (including its subsidiaries and affiliates, hereafter referred to as “Zydus”) has received final approval from the U.S. Food and Drug Administration (USFDA) to […]